Page Venture Gallery Venture Gallery View startups founded from across the University of Chicago ecosystem in a range of industries. Welcome to the Venture Gallery! The Polsky Center provides “first look” and early...
News AbbVie Joins UChicago to Talk Oncology Research, Ongoing Collaboration, and Opportunities for Expansion The annual UChicago-AbbVie Research Symposium in August celebrated another successful year of the strategic partnership – bringing together academia and industry to exchange new ideas and drive innovation. The event...
News Duckworth Family’s Partnership Drives Cancer Discoveries to Market A $1 million gift will establish the Duckworth Family Cancer Fund at the University of Chicago Medicine to accelerate the pace of cancer discoveries brought to market.
Technology Prolactin Receptor Antibodies For Targeted Cancer Therapy And Diagnosis Novel antibodies precisely targeting cancer cells by binding to the Prolactin Receptor (PRLR) to diagnose cancer, direct immune cells to destroy tumors, and inhibit cancer growth signals, without affecting healthy…
News Met With Too Many Late-Stage Diagnoses, Doctors Create Novel Test to Earlier Detect Cancer in Your Saliva OrisDX has developed a novel saliva-based molecular test to detect and diagnose oral cancer earlier – improving patient outcomes and saving lives. The Chicago-based startup was formed based on a...
Technology A Primary 3D Culture Model for the High Throughput Ex-vivo Modeling of Ovarian Cancer Metastasis Current high throughput screens for ovarian cancer drug discovery use monolayer cell culture on plastic, and problematically cannot accurately model the cross communication between the cancer cells and the tumor…
News Novel Breast Cancer Therapy Shows Promise Moving a basic scientific finding from a lab to the clinical setting is the Holy Grail for medical researchers the world over. Suzanne Conzen, MD, professor of hematology/oncology at the...
Technology Antibody-Polymer Conjugates For Engaging T Cells To Destroy Cancer Cells An antibody linked to a polymer that connects T cells to cancer cells enabling broad cancer targeting and effective tumor cell killing without needing tumor-specific antigens The Unmet Need: Novel…
Technology Boosting Cancer Immunotherapy Or Radio-Immunotherapy For Enhanced Tumor Eradication New cancer therapy to enhance the efficacy of checkpoint inhibitor immunotherapy and radiation by blocking tumor-promoting signals from erythroid progenitor cells, which secrete artemin to advance cancer progression. This approach…
News AbbVie and UChicago Extend Collaboration to Support Preclinical Oncology Research The University of Chicago and AbbVie have announced an extended collaboration agreement through 2025 to support preclinical oncology research. To date, the collaboration has led to novel insights related to...
News AbbVie, University of Chicago Symposium to Showcase Latest Oncology Research Efforts The UChicago-AbbVie Research Symposium celebrates another successful year of strategic partnership, showcasing select innovative research efforts in oncology. Taking place Friday, August 19, 2022, the symposium aims to stimulate engagement...
News New Tumor Mapping Tech Shows Potential to Make ‘Major Impact’ on Cancer Research A new technology developed at the University of Chicago has been recognized for its potential to make a major impact on basic and clinical cancer research. Nicolas Chevrier, assistant professor...
